清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Optimal treatments and outcome measures of palmoplantar pustulosis: A systematic review and network meta‐analysis‐based comparison of treatment efficacy

医学 荟萃分析 置信区间 掌跖脓疱病 随机对照试验 优势比 梅德林 分级(工程) 系统回顾 随机效应模型 内科学 物理疗法 皮肤病科 银屑病 工程类 土木工程 政治学 法学
作者
Takemichi Fukasawa,Takashi Yamashita,Atsushi Enomoto,Asako Yoshizaki‐Ogawa,Kiyoshi Miyagawa,Shinichi Sato,Ayumi Yoshizaki
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:38 (2): 281-288 被引量:5
标识
DOI:10.1111/jdv.19499
摘要

Few studies have made direct comparisons between treatments for palmoplantar pustulosis (PPP); therefore, it is difficult to select the best treatment for each patient. To determine the best therapy and to compare reported measures of efficacy in clinical trials of systemic treatments for PPP in this systematic review and network meta-analysis. Six databases were used to perform database search on 10 July 2022. Randomized controlled trials (RCTs) were identified through a systematic literature search. The titles and abstracts of articles were initially screened for inclusion by two authors independently using our predetermined criteria. The full texts of selected articles were then independently assessed for inclusion in a blinded fashion. Disagreement between the authors was resolved by consensus. Data were abstracted in duplicate. Random-effects model was accepted to perform network meta-analysis. Assessed Grading of Recommendations Assessment, Development and Evaluation certainty of evidence were performed according to the PRISMA guidelines. The analysis was completed in July 2022. The primary outcome was the change of PPP Area and Severity Index (PPPASI) from baseline and the secondary outcome was the achievement of PPPASI-50 response. Seven RCTs with 567 patients were included. Guselkumab 100 mg was the one with the highest probability of reaching the proposed outcomes (mean difference [MD], -8.00; 95% confidence interval [CI], 4.88-11.11), while the achievement of PPPASI-50 response did not show a significant difference (odds ratio [OR], 3.79; 95% CI, 0.51-28.37). Guselkumab 200 mg was next to 100 mg of reaching the proposed outcomes (MD, -4.71; 95% CI, 2.12-7.30), while the achievement of PPPASI-50 response did not show a significant difference (OR, 2.34; 95% CI, 0.48-11.43). Network meta-analysis showed guselkumab 100 mg was the treatment with the highest probability of reaching both PPPASI and PPPASI-50 outcomes. Absolute PPPASI may be more appropriate as an outcome than PPPASI-50.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
兴奋乞完成签到,获得积分10
12秒前
零度空间完成签到,获得积分10
13秒前
痴情的不惜完成签到,获得积分10
23秒前
25秒前
整齐念薇完成签到,获得积分10
25秒前
武雨寒发布了新的文献求助10
29秒前
43秒前
诸葛平卉完成签到 ,获得积分10
43秒前
星辰大海的应助被psm采纳,获得10
47秒前
47秒前
飞天大南瓜完成签到,获得积分10
49秒前
Gilgardea发布了新的文献求助10
52秒前
车车完成签到 ,获得积分10
58秒前
精明开山完成签到,获得积分10
59秒前
1分钟前
鲤鱼遥完成签到,获得积分10
1分钟前
cat发布了新的文献求助10
1分钟前
AG完成签到,获得积分10
1分钟前
田田完成签到 ,获得积分10
1分钟前
1分钟前
等待凡英完成签到,获得积分10
1分钟前
陈荆洲完成签到,获得积分10
1分钟前
高高的玉兰完成签到,获得积分10
1分钟前
1分钟前
小二郎的应助被cat采纳,获得10
1分钟前
科研通AI6.2的应助被pitinmoon采纳,获得10
1分钟前
漂亮秋荷完成签到,获得积分10
1分钟前
腼腆的雪珊完成签到,获得积分10
1分钟前
淡淡傲柔完成签到,获得积分10
1分钟前
hyk完成签到 ,获得积分10
2分钟前
Orange的应助被Gilgardea采纳,获得10
2分钟前
安详的老五完成签到,获得积分10
2分钟前
欢呼的听枫完成签到,获得积分10
2分钟前
顺利大有完成签到,获得积分10
2分钟前
满意的伊完成签到,获得积分10
3分钟前
年轻的幼菱完成签到,获得积分10
3分钟前
诺一44发布了新的文献求助10
3分钟前
limengyao完成签到,获得积分10
3分钟前
欢呼的访文完成签到,获得积分10
3分钟前
迷茫的一代完成签到,获得积分0
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166413
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750478
捐赠科研通 7757221
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553489
邀请新用户注册赠送积分活动 2473835